AUG 12, 2020 6:16 AM PDT

Genomic study of cervical cancers in sub-Saharan Africa

A first-of-its-kind study provides a comprehensive genomic study of cervical cancers in sub-Saharan Africa. Sub-Saharan African countries have the highest death rates of cervical cancer in the world, accounting for 19 of the 20 countries with the highest global rates. Every year the disease kills 300,000 women, most of them in sub-Saharan countries.

The genomic study hones in on tumors from 212 Ugandan patients with cervical cancer. Led by Akinyemi I. Ojesina, M.D., Ph.D., University of Alabama at Birmingham, in collaboration with international colleagues, the study analyzed mutational changes in the DNA of the tumor cells. In contrast to other genomic studies, this one "is the first cervical cancer study to focus on whole-genome sequencing of all samples -- as opposed to whole-exome -- leading to the identification of noncoding alterations," says Ojesina.

Additionally, says Ojesina, "This study is novel as the first cervical cancer study in which the majority of patients were positive for HIV -- the virus that causes AIDS. This allowed the identification of genomic features that distinguish HIV-positive and HIV-negative patients."

The researchers analyzed gene transcripts to identify overexpressed and down-regulated genes, in addition to looking at non-mutational, or epigenetic, changes that can affect gene regulation. In some of the tumors in the study, they found specific histone variants that can regulate gene expression, noting that histone modification at HPV integration events was correlated with the upregulation of nearby genes and endogenous retroviruses.

Ojesina explains that this study fills in gaps in the Cancer Genome Atlas, which is severely lacking data on cervical cancers in sub-Saharan Africa. Hinting at the inequity in cancer databases, Ojesina comments that the study "is novel for the identification of unique genomic features associated with the African cohort compared with The Cancer Genome Atlas."

Photo: Pixabay

"Large-scale genomics studies like this are important," conclude the study’s co-authors, "particularly in under-represented ancestry groups, to understand molecular phenotypes of these cancers, which can lead to improved treatment options."

The study was published in Nature Genetics under the title, "Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes."

Sources: Nature Genetics, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 07, 2021
Cancer
Pandemic times haven't been fun for anyone, but they've been especially hard for cancer patients
MAY 07, 2021
Pandemic times haven't been fun for anyone, but they've been especially hard for cancer patients
The pandemic hit everyone hard on many levels; now, new research from UCSF published in Cancer reports that cancer patie ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUN 09, 2021
Technology
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
JUN 09, 2021
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
In a recent study published in Nature Medicine, researchers at the Princess Margaret Cancer Centre offer evidence for th ...
JUN 11, 2021
Cancer
Man beats brain cancer with ketogenic diet
JUN 11, 2021
Man beats brain cancer with ketogenic diet
Glioblastoma brain cancer continues to be one of the most fatal cancers, responsible for approximately 15,000 death ever ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
JUL 12, 2021
Cell & Molecular Biology
A Molecule From the Gut Microbiome May Fight Tumors
JUL 12, 2021
A Molecule From the Gut Microbiome May Fight Tumors
The more we learn abut the gut microbiome, the more it seems that the microorganisms in our gastrointestinal tracts can ...
Loading Comments...